Mark Olesnavage - Board Observer @ Trapelo Health - Crunchbase Person Profile

Start Free Trial

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Primary Job Title Board Observer
Primary Organization
Trapelo Health

Gender Male

Investor Type
obfuscated
obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Tolera Therapeutics	Hopen Life Science Ventures	Yes	Series B - Tolera Therapeutics	obfuscated obfuscation

Board and Advisor Roles

Number of Current Board & Advisor Roles

Mark Olesnavage

is the

Board Observer

at

.

Trapelo Health Board ObserverJan 1, 2016

Related Hubs

Hub Name	CB Rank (Hub)
Information Services Acquired Companies With Fewer Than 50 Employees	8,409
Information Services Acquired Companies With Fewer Than 100 Employees	5,206
Beringea Portfolio Companies	80,772
Information Services Acquired Companies With Less Than $50M in Revenue	8,785
Medical Acquired Companies With Fewer Than 50 Employees	9,757
Oncology Acquired Companies	55,516
Ann Arbor SPARK Portfolio Companies	68,764
Oncology Companies that Exited	25,392
Medical Acquired Companies With Fewer Than 100 Employees	8,551
Acquired Oncology Companies	46,842

Recent News and Activity

There is no recent news or activity for this profile.